Search Thirty Clicks

The Golden Dose

The pen ships with more than four doses' worth in it by design. What's actually left over after the fourth injection, what the manufacturer's own guidance says about it, and what it means in milligrams if you use it anyway.

Share

The pen comes pre-filled with enough for four doses. Use it once a week, and by the fourth injection it’s meant to be finished.

Except it isn’t, quite.

There’s a bit left over. People call it the golden dose.


It’s not a mistake. The pen is deliberately overfilled from the manufacturer, so that four accurate 0.6 mL doses can actually be delivered once you account for the small amount lost when it is primed. The leftover is whatever’s left of that overfill once the priming loss has been taken out.

How much that comes to isn’t a fixed number. Some people report barely anything worth bothering with. Others describe drawing it out with a U-40 insulin syringe — 1 mL capacity — and filling it, or close to it. The manufacturer doesn’t give a figure either, because it genuinely can’t: however much survives to the end depends on how much was lost priming that specific pen, and that varies from one to the next.

Lilly has apparently changed the hardware over this. Newer batches of the pen are meant to leave noticeably less behind — which is a fairly clear admission that the leftover existed, and mattered enough to actually redesign for.

I don’t think that closes the gap completely, though. A pen like this delivers a dose by pushing a plunger through the cartridge. However well they’ve engineered it, that plunger still has to have some fluid ahead of it right up to the last dose, or the mechanism runs dry and starts pushing air instead of medication on injection four. You can shrink the margin. I don’t see how you get it to genuinely nothing without risking the pen failing to deliver properly on its final click. So even on the redesigned pens, there’s probably still something there. Just less of it.


Once it’s actually in a syringe, though, you do know what you’ve got. That’s what the markings on the barrel are for. Draw up 0.3 mL, it tells you it’s 0.3 mL. Draw up a full 1 mL, it tells you that too.

What you’re measuring is volume. Turning that into an amount of actual medication depends on which pen you’re using. A 2.5 mg pen delivers 2.5 mg in its 0.6 mL dose, which works out at roughly 4.17 mg per mL. Draw a full 1 mL of leftover from that pen, at that concentration, and you’re looking at somewhere around 4.17 mg — well past the 2.5 mg you’re actually prescribed, from a single extra injection.

That’s the number that actually matters. Not whether the leftover is “real medication” — it obviously is. It’s how many milligrams you’d be adding, and whether that has any relationship to what you’re supposed to be taking.


The manufacturer’s own instruction on this is one line:

Any excess solution in the pen after use should be discarded.

That’s a disposal instruction, not a description of the leftover having gone off or turned dangerous. It’s Lilly saying the pen is validated for four doses and nothing else, and that anything beyond that falls outside what they’ve tested and are willing to stand behind. It isn’t a claim that the residual has changed into something unsafe.

Which leaves a fairly obvious gap between what’s officially sanctioned and what some people actually go on to do with it.

Using a new sterile needle and syringe, on a pen only you’ve ever accessed, to draw out and inject something chemically identical to the four doses you’ve already had that month — that’s not obviously the same category of risk as “unknown substance, don’t touch it.” But it is a step the manufacturer hasn’t validated, hasn’t measured for accuracy, and won’t stand behind if it goes wrong. “Discard the excess” isn’t scaremongering. It’s them drawing a line around exactly what they’ll vouch for.


So the honest version isn’t “golden dose: dangerous” or “golden dose: free extra Mounjaro.”

It’s less exciting than either of those: it’s real medication, at a volume nobody can predict in advance, that the manufacturer has explicitly told you to throw away — not because they’ve identified something specifically wrong with it, but because it sits outside the four doses they’ve actually validated the pen to deliver.

What anyone does with that gap is a decision. Not a technicality.

Keep reading